FDA Approval Activities for this Drug
Naropin (ropivacaine HCl) Injection,Rx AstraZeneca L.P. NDA 20-533/S-002 11/2/00
Naropin Indication:for the production of local or regional anesthesia for surgery and for acute pain management. Naropin (ropivacaine HCl) Injection, AstraZeneca, Labeling Revision | Naropin (ropivacaine HCl) Injection, Abraxis BioScience, Labeling Revision